X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1995) 1995
index medicus (1704) 1704
ginsenosides - pharmacology (1621) 1621
pharmacology & pharmacy (1523) 1523
ginsenosides (1428) 1428
humans (1144) 1144
male (1131) 1131
rats (1047) 1047
mice (940) 940
panax - chemistry (829) 829
ginseng (724) 724
chemistry, medicinal (675) 675
apoptosis (568) 568
saponins (545) 545
ginsenoside (536) 536
rats, sprague-dawley (506) 506
panax-ginseng (501) 501
saponins - pharmacology (453) 453
panax ginseng (446) 446
female (436) 436
ginsenosides - chemistry (429) 429
cells (376) 376
dose-response relationship, drug (376) 376
plant sciences (363) 363
expression (354) 354
apoptosis - drug effects (352) 352
integrative & complementary medicine (345) 345
biochemistry & molecular biology (329) 329
cells, cultured (329) 329
ginsenoside rg1 (322) 322
in-vitro (321) 321
plant extracts - pharmacology (321) 321
activation (307) 307
cell line, tumor (307) 307
panax (307) 307
oxidative stress (306) 306
analysis (302) 302
ginsenosides - therapeutic use (302) 302
pharmacology (293) 293
cell proliferation - drug effects (268) 268
plants, medicinal (265) 265
ginsenoside rb1 (254) 254
ginsenosides - isolation & purification (239) 239
cell survival - drug effects (235) 235
ginsenosides - administration & dosage (235) 235
inhibition (235) 235
cancer (232) 232
cell line (225) 225
drugs, chinese herbal - pharmacology (224) 224
metabolism (219) 219
signal transduction - drug effects (208) 208
inflammation (207) 207
chemistry, multidisciplinary (206) 206
phytotherapy (205) 205
mice, inbred c57bl (197) 197
disease models, animal (194) 194
chemistry, analytical (189) 189
research (188) 188
chromatography, high pressure liquid (186) 186
neurosciences (186) 186
neuroprotective agents - pharmacology (185) 185
rats, wistar (183) 183
health aspects (175) 175
pharmacokinetics (175) 175
medicine, research & experimental (173) 173
cell biology (170) 170
ginsenosides - metabolism (166) 166
molecular structure (166) 166
compound k (165) 165
ginsenoside rg3 (163) 163
research article (163) 163
american ginseng (160) 160
metabolites (159) 159
mass spectrometry (158) 158
proteins (154) 154
plant extracts - chemistry (153) 153
phosphorylation (152) 152
brain (150) 150
gene expression (150) 150
signal transduction (150) 150
food science & technology (149) 149
mechanisms (149) 149
antineoplastic agents, phytogenic - pharmacology (147) 147
care and treatment (143) 143
herbal medicine (142) 142
rodents (141) 141
time factors (141) 141
blotting, western (136) 136
oxidative stress - drug effects (136) 136
physiological aspects (135) 135
neurons - drug effects (134) 134
nitric-oxide (133) 133
mice, inbred icr (131) 131
nf-kappa-b (131) 131
red ginseng (130) 130
growth (129) 129
plant roots - chemistry (129) 129
nitric oxide (127) 127
proliferation (126) 126
panax notoginseng (125) 125
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3971) 3971
Chinese (349) 349
Japanese (123) 123
Korean (14) 14
Russian (7) 7
German (2) 2
Portuguese (2) 2
Czech (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 10/2009, Volume 29, Issue 41, pp. 12982 - 12993
Estrogen, in addition to its genomic effects in brain, causes rapid and reversible changes to synaptic operations. We report here that these acute actions are... 
SPRAGUE-DAWLEY RATS | INDUCED INCREASE | DENDRITIC SPINE DENSITY | NEUROTROPHIC FACTOR | ACTIN POLYMERIZATION | HIPPOCAMPAL PYRAMIDAL NEURONS | LIM-KINASE | REPLACEMENT THERAPY | LONG-TERM POTENTIATION | NEUROSCIENCES | ESTROUS-CYCLE | Estradiol - analogs & derivatives | Synaptic Transmission - physiology | Age Factors | Rats, Long-Evans | Actins - metabolism | Neuronal Plasticity - drug effects | Estrogen Antagonists - pharmacology | Male | Neurons - cytology | Ginsenosides - pharmacology | Excitatory Postsynaptic Potentials - drug effects | Neural Pathways - physiology | Patch-Clamp Techniques - methods | Dose-Response Relationship, Drug | Excitatory Postsynaptic Potentials - physiology | Sapogenins - pharmacology | Neuronal Plasticity - physiology | Long-Term Potentiation - drug effects | Dendritic Spines - drug effects | Neurons - physiology | Female | Synaptic Transmission - drug effects | Estrogens - metabolism | Neurons - drug effects | Thiazolidines - pharmacology | Electric Stimulation - methods | Estradiol - pharmacology | Phenols - pharmacology | Animals, Newborn | Dendritic Spines - physiology | Rats | Excitatory Amino Acid Antagonists - pharmacology | Ovariectomy - methods | Biophysics | Hippocampus - cytology | Rats, Sprague-Dawley | GABA Antagonists - pharmacology | Microscopy, Confocal | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Analysis of Variance | Signal Transduction - drug effects | Cytoskeleton - metabolism | Picrotoxin - pharmacology | Oxazoles - pharmacology | In Vitro Techniques
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 01/2006, Volume 33, Issue 1, pp. 27 - 32
SUMMARY • The aim of the present study was to clarify the role of ginsenoside Rh2 as the active compound in Panax ginseng root for lowering plasma glucose in... 
Wistar rats | ginsenosides Rh2 | acetylcholine | insulin | muscarinic M3 receptors | Muscarinic M | Acetylcholine | receptors | Ginsenosides Rh2 | Insulin | CELLS | PHYSIOLOGY | STIMULATION | PANAX-GINSENG | PERFORMANCE | RELEASE | MUSCARINIC ACETYLCHOLINE-RECEPTOR | INTESTINAL BACTERIA | PHARMACOKINETICS | HYPOGLYCEMIC ACTIVITY | PHARMACOLOGY & PHARMACY | MICE | muscarinic M-3 receptors | Injections, Intravenous | C-Peptide - blood | Enzyme-Linked Immunosorbent Assay | Rats, Wistar | Cholinergic Agents - pharmacology | Drugs, Chinese Herbal - pharmacology | Rats | Atropine - pharmacology | Male | Ginsenosides - pharmacology | Insulin - blood | Dose-Response Relationship, Drug | Insulin - metabolism | Animals | Piperidines - pharmacology | Hemicholinium 3 - pharmacology | Muscarinic Antagonists - pharmacology | Ginsenosides - administration & dosage | Blood Glucose - metabolism | Insulin Secretion | Neuromuscular Depolarizing Agents - pharmacology | Ginsenosides, administration and dosage | Atropine, pharmacology | Insulin, secretion | Insulin, blood | C-Peptide, blood | Blood Glucose, metabolism | Hemicholinium 3, pharmacology | Piperidines, pharmacology | Cholinergic Agents, pharmacology | Drugs, Chinese Herbal, pharmacology | Muscarinic Antagonists, pharmacology | Neuromuscular Depolarizing Agents, pharmacology | Ginsenosides, pharmacology
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 09/2015, Volume 762, pp. 333 - 343
Journal Article
American Journal of Chinese Medicine, ISSN 0192-415X, 2016, Volume 44, Issue 8, pp. 1525 - 1541
Alzheimer's disease (AD), the most common neurodegenerative disorder associated with dementia, not only severely decreases the quality of life for its victims,... 
Review | Chinese Medicine | Active Components | Alzheimer's Disease | OXIDATIVE-STRESS | STRESS-INDUCED APOPTOSIS | GINKGO-BILOBA EXTRACT | PROTECTS | MEDICINE, GENERAL & INTERNAL | IN-VITRO | AMYLOID-INDUCED NEUROTOXICITY | INTEGRATIVE & COMPLEMENTARY MEDICINE | TANSHINONE IIA | TRANSGENIC MOUSE MODEL | PC12 CELLS | GINSENOSIDE RG1 | Plant Extracts - chemistry | Sesquiterpenes - isolation & purification | Epimedium - chemistry | Evodia - chemistry | Humans | Alkaloids - isolation & purification | Diterpenes, Abietane - isolation & purification | Ginsenosides - pharmacology | Flavonoids - therapeutic use | Ginsenosides - therapeutic use | Sesquiterpenes - therapeutic use | Flavonoids - pharmacology | Phytotherapy | Drugs, Chinese Herbal - therapeutic use | Scutellaria baicalensis - chemistry | Alkaloids - pharmacology | Curcumin - therapeutic use | Huperzia - chemistry | Diterpenes, Abietane - therapeutic use | Curcumin - pharmacology | Alzheimer Disease - drug therapy | Curcumin - isolation & purification | Quinazolines - isolation & purification | Diterpenes, Abietane - pharmacology | Salvia miltiorrhiza - chemistry | Panax - chemistry | Drugs, Chinese Herbal - chemistry | Quinazolines - therapeutic use | Ginsenosides - isolation & purification | Alkaloids - therapeutic use | Flavonoids - isolation & purification | Sesquiterpenes - pharmacology | Quinazolines - pharmacology | Curcuma - chemistry | Alzheimer's disease | Care and treatment
Journal Article
Journal Article
Journal of Neuroscience Research, ISSN 0360-4012, 10/2014, Volume 92, Issue 10, pp. 1295 - 1306
SMXZF is a combination of Rb1, Rg1, schizandrin, and DT‐13 (6:9:5:4) derived from Sheng‐mai San, a widely used Chinese traditional medicine for the treatment... 
autophagy | signaling pathways | cerebral ischemia–reperfusion | 3‐MA | SMXZF | Signaling pathways | 3-MA | Autophagy | Cerebral ischemia-reperfusion | KAPPA-B ACTIVATION | ISCHEMIA/REPERFUSION INJURY | BECLIN 1 | ARTERY OCCLUSION | OXIDATIVE DAMAGE | NEUROSCIENCES | CELL-DEATH | cerebral ischemia-reperfusion | SHENGMAI-SAN | MOUSE MODEL | IN-VIVO | GINSENOSIDE RG1 | Neuroprotective Agents - therapeutic use | TOR Serine-Threonine Kinases - metabolism | Male | Ginsenosides - pharmacology | Infarction, Middle Cerebral Artery - metabolism | Lignans - pharmacology | Autophagy - drug effects | Ginsenosides - therapeutic use | Lignans - therapeutic use | Brain - metabolism | Brain Infarction - prevention & control | Dose-Response Relationship, Drug | Brain - blood supply | Neuroprotective Agents - pharmacology | Time Factors | Brain - ultrastructure | Renal Circulation - drug effects | Saponins - therapeutic use | Cyclooctanes - pharmacology | Infarction, Middle Cerebral Artery - drug therapy | Drugs, Chinese Herbal - therapeutic use | Disease Models, Animal | Adenine - analogs & derivatives | Neuroprotective Agents - chemistry | Reperfusion Injury - pathology | Mice, Inbred C57BL | Adenine - pharmacology | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - metabolism | Infarction, Middle Cerebral Artery - pathology | Cyclooctanes - therapeutic use | Polycyclic Compounds - pharmacology | Brain Infarction - etiology | Animals | MAP Kinase Signaling System - drug effects | Reperfusion Injury - prevention & control | Brain - pathology | Mice | Polycyclic Compounds - therapeutic use | Drug Combinations | Saponins - pharmacology | Cerebral ischemia | Reperfusion injury
Journal Article
Cancer Letters, ISSN 0304-3835, 2010, Volume 301, Issue 2, pp. 185 - 192
Journal Article